AC Immune SA (ACIU)
1.95
-0.18
(-8.45%)
USD |
NASDAQ |
Nov 20, 16:00
1.99
+0.04
(+2.05%)
After-Hours: 20:00
AC Immune Cash and Short Term Investments (Annual) : 115.38M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 115.38M |
| December 31, 2024 | 182.61M |
| December 31, 2023 | 122.44M |
| December 31, 2022 | 132.50M |
| December 31, 2021 | 217.54M |
| December 31, 2020 | 255.55M |
| Date | Value |
|---|---|
| December 31, 2019 | 298.02M |
| December 31, 2018 | 189.15M |
| December 31, 2017 | 127.63M |
| December 31, 2016 | 149.76M |
| December 31, 2015 | 76.45M |
| December 31, 2014 | 3.327M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Precigen, Inc. | 97.86M |
| Basilea Pharmaceutica AG | 204.91M |
| Santhera Pharmaceuticals Holding AG | 28.32M |
| Aldeyra Therapeutics, Inc. | 70.04M |
| BeOne Medicines Ltd. | 4.589B |